Janssen Pharmaceutical K.K.
Registry sponsor category
Industry
- Other names
- Janssen Pharmaceutical K.K.
- Company name
- Janssen Pharmaceutical K.K.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Website
- https://innovativemedicine.jnj.com/
- Publicly traded (proxy)
- No
- Listing at source
- Listed
- Wikidata ID
- Q903523
Related records
Trials (129)
- A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia
- A Comparative Study of JNS013 in Participants With Post-Tooth-Extraction Pain
- A Confirmatory Study of Fentanyl in Participants With Osteoarthritis or Low Back Pain
- A Confirmatory Study of Fentanyl in Participants With Post-herpetic Neuralgia, Complex Regional Pain Syndrome or Postoperative Pain Syndrome
- A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain
- A Dose-Finding Study of Topiramate (JNS019) in Participants With Migraine
- A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients
- A Long-term Efficacy and Safety Study of Tramadol Hydrochloride Plus Acetaminophen (JNS013) in Japanese Participants With Chronic Pain
- A Long-Term Study of JNS007ER in Patients With Schizophrenia
- A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
- A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia
- A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients
- A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection
- A Phase 1 Study of CNTO 328 (Siltuximab) in Relapsed or Refractory Multiple Myeloma
- A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia
- A Phase 4 Study to Evaluate Pharmacokinetics and Safety of Darunavir Along With Ritonavir in Healthy Male Japanese Participants
- A Phase III Study of TMC435 in Genotype 1, Hepatitis C-infected Participants Who Failed to Respond to Previous IFN-based Therapy
- A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients
- A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan
- A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan